Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Rachel Porth, M.D.


Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
  1. Dussel V, Orellana L, Holder R, Porth R, Avery M, Wolfe J. A multisite randomized controlled trial of an early palliative care intervention in children with advanced cancer: The PediQUEST Response Study Protocol. PLoS One. 2022; 17(11):e0277212. PMID: 36346783; PMCID: PMC9642881.
    Citations:    Fields:    Translation:HumansCTClinical Trials
  2. Rizvi M, Smilansky H, Porth R, Myers N, Geller D, Small BJ, McGuire JF, Wilhelm S, Storch EA. The moderating effect of age on the associations of cognitive and metacognitive beliefs with pediatric OCD symptoms. Cogn Behav Ther. 2021 03; 50(2):104-120. PMID: 33073722; PMCID: PMC7897238.
    Citations: 2     Fields:    Translation:Humans
  3. Bakhshaie J, Geller DA, Wilhelm S, McGuire JF, Small BJ, Cepeda SL, Schneider SC, Murphy TK, Porth R, Storch EA. Temporal precedence of the change in obsessive-compulsive symptoms and change in depressive symptoms during exposure and response prevention for pediatric obsessive-compulsive disorders. Behav Res Ther. 2020 Jul 28; 133:103697. PMID: 32822898; PMCID: PMC9547150.
    Citations:    Fields:    
  4. Fang A, Porth R, Phillips KA, Wilhelm S. Personality as a Predictor of Treatment Response to Escitalopram in Adults With Body Dysmorphic Disorder. J Psychiatr Pract. 2019 09; 25(5):347-357. PMID: 31505519.
    Citations:    Fields:    Translation:Humans
  5. Geller DA, McGuire JF, Orr SP, Small BJ, Murphy TK, Trainor K, Porth R, Wilhelm S, Storch EA. Fear extinction learning as a predictor of response to cognitive behavioral therapy for pediatric obsessive compulsive disorder. J Anxiety Disord. 2019 05; 64:1-8. PMID: 30852257.
    Citations: 13     Fields:    Translation:Humans
  6. Wilhelm S, Berman N, Small BJ, Porth R, Storch EA, Geller D. D-Cycloserine augmentation of cognitive behavior therapy for pediatric OCD: Predictors and moderators of outcome. J Affect Disord. 2018 12 01; 241:454-460. PMID: 30149332.
    Citations: 1     Fields:    Translation:Humans
  7. Porth R, Geller D. Atypical symptom presentations in children and adolescents with obsessive compulsive disorder. Compr Psychiatry. 2018 10; 86:25-30. PMID: 30048852.
    Citations: 1     Fields:    Translation:Humans
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: HMS/HSDM faculty should contact contactcatalyst.harvard.edu. For faculty or fellow appointment updates and changes, please ask your appointing department to contact HMS. For fellow personal and demographic information, contact HMS Human Resources at human_resourceshms.harvard.edu. For faculty personal and demographic information, contact HMS Office for Faculty Affairs at facappthms.harvard.edu.
Porth's Networks
Click the
buttons for more information and interactive visualizations!
Concepts (35)
Co-Authors (5)
Similar People (60)
Same Department 
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.